These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9144321)

  • 1. Minimally modified low density lipoproteins induce aortic smooth muscle cell proliferation via the activation of mitogen activated protein kinase.
    Balagopalakrishna C; Bhunia AK; Rifkind JM; Chatterjee S
    Mol Cell Biochem; 1997 May; 170(1-2):85-9. PubMed ID: 9144321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells.
    Chatterjee S; Bhunia AK; Snowden A; Han H
    Glycobiology; 1997 Jul; 7(5):703-10. PubMed ID: 9254052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity.
    Jing Q; Xin SM; Cheng ZJ; Zhang WB; Zhang R; Qin YW; Pei G
    Circ Res; 1999 Apr; 84(7):831-9. PubMed ID: 10205151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth-promoting effect of low-density lipoprotein may Be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway.
    Sachinidis A; Seewald S; Epping P; Seul C; Ko Y; Vetter H
    Mol Pharmacol; 1997 Sep; 52(3):389-97. PubMed ID: 9281600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein.
    Augé N; Escargueil-Blanc I; Lajoie-Mazenc I; Suc I; Andrieu-Abadie N; Pieraggi MT; Chatelut M; Thiers JC; Jaffrézou JP; Laurent G; Levade T; Nègre-Salvayre A; Salvayre R
    J Biol Chem; 1998 May; 273(21):12893-900. PubMed ID: 9582320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells.
    Velarde V; Jenkins AJ; Christopher J; Lyons TJ; Jaffa AA
    J Appl Physiol (1985); 2001 Sep; 91(3):1412-20. PubMed ID: 11509543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation.
    Chatterjee S; Ghosh N
    Glycobiology; 1996 Apr; 6(3):303-11. PubMed ID: 8724138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors.
    Lin SJ; Shyue SK; Shih MC; Chu TH; Chen YH; Ku HH; Chen JW; Tam KB; Chen YL
    Atherosclerosis; 2007 Jan; 190(1):124-34. PubMed ID: 16600249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
    Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
    Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitogen-activated protein kinase pathway contributes to vanadate toxicity in vascular smooth muscle cells.
    Daum G; Levkau B; Chamberlain NL; Wang Y; Clowes AW
    Mol Cell Biochem; 1998 Jun; 183(1-2):97-103. PubMed ID: 9655183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases.
    Locher R; Brandes RP; Vetter W; Barton M
    Hypertension; 2002 Feb; 39(2 Pt 2):645-50. PubMed ID: 11882624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells.
    Liu Y; Liu G
    Biochem Pharmacol; 2004 Feb; 67(4):777-85. PubMed ID: 14757178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension.
    Begum N; Song Y; Rienzie J; Ragolia L
    Am J Physiol; 1998 Jul; 275(1):C42-9. PubMed ID: 9688833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway.
    Yang CM; Chien CS; Hsiao LD; Pan SL; Wang CC; Chiu CT; Lin CC
    Br J Pharmacol; 2001 Apr; 132(7):1531-41. PubMed ID: 11264247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK.
    Lu LH; Lee SS; Huang HC
    Br J Pharmacol; 1998 Jul; 124(6):1227-37. PubMed ID: 9720795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages.
    Kusuhara M; Chait A; Cader A; Berk BC
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):141-8. PubMed ID: 9012649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.
    Yu SM; Chen SF; Lau YT; Yang CM; Chen JC
    Mol Pharmacol; 1996 Oct; 50(4):1000-9. PubMed ID: 8863847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase.
    Hu ZW; Shi XY; Lin RZ; Chen J; Hoffman BB
    J Pharmacol Exp Ther; 1999 Jul; 290(1):28-37. PubMed ID: 10381756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase.
    Niculescu F; Badea T; Rus H
    Atherosclerosis; 1999 Jan; 142(1):47-56. PubMed ID: 9920505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway.
    Yu SM; Hung LM; Lin CC
    Circulation; 1997 Mar; 95(5):1269-77. PubMed ID: 9054859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.